Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing concentrated safety monitoring of Xuebijing injection
ChiCTR-OCS-13003574Phase 4Recruiting
- Sponsor
- Tianjin TCM Institute of Clinical Evaluation
- Start
- Sep 2013
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of xuebijing in Infectious disease, sponsored by Tianjin TCM Institute of Clinical Evaluation. Primary endpoint: Adverse drug reactions. Started Sep 2013; status: recruiting.
02
Drugs
xuebijing
03
Conditions
Infectious disease
Beyond the preview
Go deeper on ChiCTR-OCS-13003574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCS-13003574.